Global Injectable Drug Delivery Formulation Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Injectable Drug Delivery Formulation will have significant change from previous year. According to our (LP Information) latest study, the global Injectable Drug Delivery Formulation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Injectable Drug Delivery Formulation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Injectable Drug Delivery Formulation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Injectable Drug Delivery Formulation market, reaching US$ million by the year 2028. As for the Europe Injectable Drug Delivery Formulation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Injectable Drug Delivery Formulation players cover Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), and Pfizer, Inc. (US), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Drug Delivery Formulation market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Injectable Drug Delivery Formulation will have significant change from previous year. According to our (LP Information) latest study, the global Injectable Drug Delivery Formulation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Injectable Drug Delivery Formulation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Injectable Drug Delivery Formulation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Injectable Drug Delivery Formulation market, reaching US$ million by the year 2028. As for the Europe Injectable Drug Delivery Formulation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Injectable Drug Delivery Formulation players cover Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), and Pfizer, Inc. (US), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Drug Delivery Formulation market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Conventional Drug Delivery Formulations
- Novel Drug Delivery Formulations
- Long-acting Formulations
- Autoimmune Diseases
- Hormonal Disorders
- Oncology
- Orphan Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Becton, Dickinson and Company (US)
- Baxter International Inc. (US)
- Gerresheimer AG (Germany)
- Pfizer, Inc. (US)
- Schott AG (Germany)
- Sandoz (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Eli Lilly and Company (US)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable Drug Delivery Formulation Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Injectable Drug Delivery Formulation by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Injectable Drug Delivery Formulation by Country/Region, 2017, 2022 & 2028
2.2 Injectable Drug Delivery Formulation Segment by Type
2.2.1 Conventional Drug Delivery Formulations
2.2.2 Novel Drug Delivery Formulations
2.2.3 Long-acting Formulations
2.3 Injectable Drug Delivery Formulation Sales by Type
2.3.1 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
2.3.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Type (2017-2022)
2.3.3 Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022)
2.4 Injectable Drug Delivery Formulation Segment by Application
2.4.1 Autoimmune Diseases
2.4.2 Hormonal Disorders
2.4.3 Oncology
2.4.4 Orphan Diseases
2.4.5 Others
2.5 Injectable Drug Delivery Formulation Sales by Application
2.5.1 Global Injectable Drug Delivery Formulation Sale Market Share by Application (2017-2022)
2.5.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Application (2017-2022)
2.5.3 Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022)
3 GLOBAL INJECTABLE DRUG DELIVERY FORMULATION BY COMPANY
3.1 Global Injectable Drug Delivery Formulation Breakdown Data by Company
3.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Company (2020-2022)
3.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)
3.2 Global Injectable Drug Delivery Formulation Annual Revenue by Company (2020-2022)
3.2.1 Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022)
3.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)
3.3 Global Injectable Drug Delivery Formulation Sale Price by Company
3.4 Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Drug Delivery Formulation Product Location Distribution
3.4.2 Players Injectable Drug Delivery Formulation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE DRUG DELIVERY FORMULATION BY GEOGRAPHIC REGION
4.1 World Historic Injectable Drug Delivery Formulation Market Size by Geographic Region (2017-2022)
4.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Injectable Drug Delivery Formulation Annual Revenue by Geographic Region
4.2 World Historic Injectable Drug Delivery Formulation Market Size by Country/Region (2017-2022)
4.2.1 Global Injectable Drug Delivery Formulation Annual Sales by Country/Region (2017-2022)
4.2.2 Global Injectable Drug Delivery Formulation Annual Revenue by Country/Region
4.3 Americas Injectable Drug Delivery Formulation Sales Growth
4.4 APAC Injectable Drug Delivery Formulation Sales Growth
4.5 Europe Injectable Drug Delivery Formulation Sales Growth
4.6 Middle East & Africa Injectable Drug Delivery Formulation Sales Growth
5 AMERICAS
5.1 Americas Injectable Drug Delivery Formulation Sales by Country
5.1.1 Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022)
5.1.2 Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
5.2 Americas Injectable Drug Delivery Formulation Sales by Type
5.3 Americas Injectable Drug Delivery Formulation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Drug Delivery Formulation Sales by Region
6.1.1 APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022)
6.1.2 APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022)
6.2 APAC Injectable Drug Delivery Formulation Sales by Type
6.3 APAC Injectable Drug Delivery Formulation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable Drug Delivery Formulation by Country
7.1.1 Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022)
7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
7.2 Europe Injectable Drug Delivery Formulation Sales by Type
7.3 Europe Injectable Drug Delivery Formulation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable Drug Delivery Formulation by Country
8.1.1 Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022)
8.1.2 Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
8.2 Middle East & Africa Injectable Drug Delivery Formulation Sales by Type
8.3 Middle East & Africa Injectable Drug Delivery Formulation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation
10.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation
10.4 Industry Chain Structure of Injectable Drug Delivery Formulation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable Drug Delivery Formulation Distributors
11.3 Injectable Drug Delivery Formulation Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE DRUG DELIVERY FORMULATION BY GEOGRAPHIC REGION
12.1 Global Injectable Drug Delivery Formulation Market Size Forecast by Region
12.1.1 Global Injectable Drug Delivery Formulation Forecast by Region (2023-2028)
12.1.2 Global Injectable Drug Delivery Formulation Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Drug Delivery Formulation Forecast by Type
12.7 Global Injectable Drug Delivery Formulation Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Becton, Dickinson and Company (US)
13.1.1 Becton, Dickinson and Company (US) Company Information
13.1.2 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered
13.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Becton, Dickinson and Company (US) Main Business Overview
13.1.5 Becton, Dickinson and Company (US) Latest Developments
13.2 Baxter International Inc. (US)
13.2.1 Baxter International Inc. (US) Company Information
13.2.2 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered
13.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baxter International Inc. (US) Main Business Overview
13.2.5 Baxter International Inc. (US) Latest Developments
13.3 Gerresheimer AG (Germany)
13.3.1 Gerresheimer AG (Germany) Company Information
13.3.2 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered
13.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gerresheimer AG (Germany) Main Business Overview
13.3.5 Gerresheimer AG (Germany) Latest Developments
13.4 Pfizer, Inc. (US)
13.4.1 Pfizer, Inc. (US) Company Information
13.4.2 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered
13.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer, Inc. (US) Main Business Overview
13.4.5 Pfizer, Inc. (US) Latest Developments
13.5 Schott AG (Germany)
13.5.1 Schott AG (Germany) Company Information
13.5.2 Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered
13.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Schott AG (Germany) Main Business Overview
13.5.5 Schott AG (Germany) Latest Developments
13.6 Sandoz (Germany)
13.6.1 Sandoz (Germany) Company Information
13.6.2 Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered
13.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sandoz (Germany) Main Business Overview
13.6.5 Sandoz (Germany) Latest Developments
13.7 Teva Pharmaceutical Industries Ltd. (Israel)
13.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
13.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments
13.8 Eli Lilly and Company (US)
13.8.1 Eli Lilly and Company (US) Company Information
13.8.2 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered
13.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eli Lilly and Company (US) Main Business Overview
13.8.5 Eli Lilly and Company (US) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable Drug Delivery Formulation Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Injectable Drug Delivery Formulation by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Injectable Drug Delivery Formulation by Country/Region, 2017, 2022 & 2028
2.2 Injectable Drug Delivery Formulation Segment by Type
2.2.1 Conventional Drug Delivery Formulations
2.2.2 Novel Drug Delivery Formulations
2.2.3 Long-acting Formulations
2.3 Injectable Drug Delivery Formulation Sales by Type
2.3.1 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
2.3.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Type (2017-2022)
2.3.3 Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022)
2.4 Injectable Drug Delivery Formulation Segment by Application
2.4.1 Autoimmune Diseases
2.4.2 Hormonal Disorders
2.4.3 Oncology
2.4.4 Orphan Diseases
2.4.5 Others
2.5 Injectable Drug Delivery Formulation Sales by Application
2.5.1 Global Injectable Drug Delivery Formulation Sale Market Share by Application (2017-2022)
2.5.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Application (2017-2022)
2.5.3 Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022)
3 GLOBAL INJECTABLE DRUG DELIVERY FORMULATION BY COMPANY
3.1 Global Injectable Drug Delivery Formulation Breakdown Data by Company
3.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Company (2020-2022)
3.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)
3.2 Global Injectable Drug Delivery Formulation Annual Revenue by Company (2020-2022)
3.2.1 Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022)
3.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)
3.3 Global Injectable Drug Delivery Formulation Sale Price by Company
3.4 Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable Drug Delivery Formulation Product Location Distribution
3.4.2 Players Injectable Drug Delivery Formulation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE DRUG DELIVERY FORMULATION BY GEOGRAPHIC REGION
4.1 World Historic Injectable Drug Delivery Formulation Market Size by Geographic Region (2017-2022)
4.1.1 Global Injectable Drug Delivery Formulation Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Injectable Drug Delivery Formulation Annual Revenue by Geographic Region
4.2 World Historic Injectable Drug Delivery Formulation Market Size by Country/Region (2017-2022)
4.2.1 Global Injectable Drug Delivery Formulation Annual Sales by Country/Region (2017-2022)
4.2.2 Global Injectable Drug Delivery Formulation Annual Revenue by Country/Region
4.3 Americas Injectable Drug Delivery Formulation Sales Growth
4.4 APAC Injectable Drug Delivery Formulation Sales Growth
4.5 Europe Injectable Drug Delivery Formulation Sales Growth
4.6 Middle East & Africa Injectable Drug Delivery Formulation Sales Growth
5 AMERICAS
5.1 Americas Injectable Drug Delivery Formulation Sales by Country
5.1.1 Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022)
5.1.2 Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
5.2 Americas Injectable Drug Delivery Formulation Sales by Type
5.3 Americas Injectable Drug Delivery Formulation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Drug Delivery Formulation Sales by Region
6.1.1 APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022)
6.1.2 APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022)
6.2 APAC Injectable Drug Delivery Formulation Sales by Type
6.3 APAC Injectable Drug Delivery Formulation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable Drug Delivery Formulation by Country
7.1.1 Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022)
7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
7.2 Europe Injectable Drug Delivery Formulation Sales by Type
7.3 Europe Injectable Drug Delivery Formulation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable Drug Delivery Formulation by Country
8.1.1 Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022)
8.1.2 Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022)
8.2 Middle East & Africa Injectable Drug Delivery Formulation Sales by Type
8.3 Middle East & Africa Injectable Drug Delivery Formulation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation
10.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation
10.4 Industry Chain Structure of Injectable Drug Delivery Formulation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable Drug Delivery Formulation Distributors
11.3 Injectable Drug Delivery Formulation Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE DRUG DELIVERY FORMULATION BY GEOGRAPHIC REGION
12.1 Global Injectable Drug Delivery Formulation Market Size Forecast by Region
12.1.1 Global Injectable Drug Delivery Formulation Forecast by Region (2023-2028)
12.1.2 Global Injectable Drug Delivery Formulation Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Drug Delivery Formulation Forecast by Type
12.7 Global Injectable Drug Delivery Formulation Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Becton, Dickinson and Company (US)
13.1.1 Becton, Dickinson and Company (US) Company Information
13.1.2 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered
13.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Becton, Dickinson and Company (US) Main Business Overview
13.1.5 Becton, Dickinson and Company (US) Latest Developments
13.2 Baxter International Inc. (US)
13.2.1 Baxter International Inc. (US) Company Information
13.2.2 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered
13.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baxter International Inc. (US) Main Business Overview
13.2.5 Baxter International Inc. (US) Latest Developments
13.3 Gerresheimer AG (Germany)
13.3.1 Gerresheimer AG (Germany) Company Information
13.3.2 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered
13.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gerresheimer AG (Germany) Main Business Overview
13.3.5 Gerresheimer AG (Germany) Latest Developments
13.4 Pfizer, Inc. (US)
13.4.1 Pfizer, Inc. (US) Company Information
13.4.2 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered
13.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer, Inc. (US) Main Business Overview
13.4.5 Pfizer, Inc. (US) Latest Developments
13.5 Schott AG (Germany)
13.5.1 Schott AG (Germany) Company Information
13.5.2 Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered
13.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Schott AG (Germany) Main Business Overview
13.5.5 Schott AG (Germany) Latest Developments
13.6 Sandoz (Germany)
13.6.1 Sandoz (Germany) Company Information
13.6.2 Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered
13.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sandoz (Germany) Main Business Overview
13.6.5 Sandoz (Germany) Latest Developments
13.7 Teva Pharmaceutical Industries Ltd. (Israel)
13.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
13.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments
13.8 Eli Lilly and Company (US)
13.8.1 Eli Lilly and Company (US) Company Information
13.8.2 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered
13.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Eli Lilly and Company (US) Main Business Overview
13.8.5 Eli Lilly and Company (US) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Injectable Drug Delivery Formulation Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Injectable Drug Delivery Formulation Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Conventional Drug Delivery Formulations
Table 4. Major Players of Novel Drug Delivery Formulations
Table 5. Major Players of Long-acting Formulations
Table 6. Global Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 7. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 8. Global Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & ($ million)
Table 9. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)
Table 10. Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022) & (USD/Pcs)
Table 11. Global Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 12. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 13. Global Injectable Drug Delivery Formulation Revenue by Application (2017-2022)
Table 14. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2022)
Table 15. Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022) & (USD/Pcs)
Table 16. Global Injectable Drug Delivery Formulation Sales by Company (2020-2022) & (K Pcs)
Table 17. Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)
Table 18. Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)
Table 20. Global Injectable Drug Delivery Formulation Sale Price by Company (2020-2022) & (USD/Pcs)
Table 21. Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution and Sales Area
Table 22. Players Injectable Drug Delivery Formulation Products Offered
Table 23. Injectable Drug Delivery Formulation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Drug Delivery Formulation Sales by Geographic Region (2017-2022) & (K Pcs)
Table 27. Global Injectable Drug Delivery Formulation Sales Market Share Geographic Region (2017-2022)
Table 28. Global Injectable Drug Delivery Formulation Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Injectable Drug Delivery Formulation Sales by Country/Region (2017-2022) & (K Pcs)
Table 31. Global Injectable Drug Delivery Formulation Sales Market Share by Country/Region (2017-2022)
Table 32. Global Injectable Drug Delivery Formulation Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 35. Americas Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 36. Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 38. Americas Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 39. Americas Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 40. Americas Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 41. Americas Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 42. APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022) & (K Pcs)
Table 43. APAC Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
Table 44. APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Injectable Drug Delivery Formulation Revenue Market Share by Region (2017-2022)
Table 46. APAC Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 47. APAC Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 48. APAC Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 49. APAC Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 50. Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 51. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 52. Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 54. Europe Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 55. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 56. Europe Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 57. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 59. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Injectable Drug Delivery Formulation
Table 67. Key Market Challenges & Risks of Injectable Drug Delivery Formulation
Table 68. Key Industry Trends of Injectable Drug Delivery Formulation
Table 69. Injectable Drug Delivery Formulation Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Injectable Drug Delivery Formulation Distributors List
Table 72. Injectable Drug Delivery Formulation Customer List
Table 73. Global Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)
Table 74. Global Injectable Drug Delivery Formulation Sales Market Forecast by Region
Table 75. Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 78. Americas Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)
Table 80. APAC Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Europe Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Injectable Drug Delivery Formulation Sales Forecast by Type (2023-2028) & (K Pcs)
Table 86. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Injectable Drug Delivery Formulation Sales Forecast by Application (2023-2028) & (K Pcs)
Table 90. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Application (2023-2028)
Table 93. Becton, Dickinson and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 94. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered
Table 95. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 96. Becton, Dickinson and Company (US) Main Business
Table 97. Becton, Dickinson and Company (US) Latest Developments
Table 98. Baxter International Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered
Table 100. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Baxter International Inc. (US) Main Business
Table 102. Baxter International Inc. (US) Latest Developments
Table 103. Gerresheimer AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 104. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered
Table 105. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Gerresheimer AG (Germany) Main Business
Table 107. Gerresheimer AG (Germany) Latest Developments
Table 108. Pfizer, Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered
Table 110. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Pfizer, Inc. (US) Main Business
Table 112. Pfizer, Inc. (US) Latest Developments
Table 113. Schott AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 114. Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered
Table 115. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. Schott AG (Germany) Main Business
Table 117. Schott AG (Germany) Latest Developments
Table 118. Sandoz (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered
Table 120. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Sandoz (Germany) Main Business
Table 122. Sandoz (Germany) Latest Developments
Table 123. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered
Table 125. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. Teva Pharmaceutical Industries Ltd. (Israel) Main Business
Table 127. Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments
Table 128. Eli Lilly and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered
Table 130. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. Eli Lilly and Company (US) Main Business
Table 132. Eli Lilly and Company (US) Latest Developments
Table 1. Injectable Drug Delivery Formulation Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Injectable Drug Delivery Formulation Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Conventional Drug Delivery Formulations
Table 4. Major Players of Novel Drug Delivery Formulations
Table 5. Major Players of Long-acting Formulations
Table 6. Global Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 7. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 8. Global Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & ($ million)
Table 9. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)
Table 10. Global Injectable Drug Delivery Formulation Sale Price by Type (2017-2022) & (USD/Pcs)
Table 11. Global Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 12. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 13. Global Injectable Drug Delivery Formulation Revenue by Application (2017-2022)
Table 14. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2022)
Table 15. Global Injectable Drug Delivery Formulation Sale Price by Application (2017-2022) & (USD/Pcs)
Table 16. Global Injectable Drug Delivery Formulation Sales by Company (2020-2022) & (K Pcs)
Table 17. Global Injectable Drug Delivery Formulation Sales Market Share by Company (2020-2022)
Table 18. Global Injectable Drug Delivery Formulation Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Company (2020-2022)
Table 20. Global Injectable Drug Delivery Formulation Sale Price by Company (2020-2022) & (USD/Pcs)
Table 21. Key Manufacturers Injectable Drug Delivery Formulation Producing Area Distribution and Sales Area
Table 22. Players Injectable Drug Delivery Formulation Products Offered
Table 23. Injectable Drug Delivery Formulation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Drug Delivery Formulation Sales by Geographic Region (2017-2022) & (K Pcs)
Table 27. Global Injectable Drug Delivery Formulation Sales Market Share Geographic Region (2017-2022)
Table 28. Global Injectable Drug Delivery Formulation Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Injectable Drug Delivery Formulation Sales by Country/Region (2017-2022) & (K Pcs)
Table 31. Global Injectable Drug Delivery Formulation Sales Market Share by Country/Region (2017-2022)
Table 32. Global Injectable Drug Delivery Formulation Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 35. Americas Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 36. Americas Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 38. Americas Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 39. Americas Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 40. Americas Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 41. Americas Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 42. APAC Injectable Drug Delivery Formulation Sales by Region (2017-2022) & (K Pcs)
Table 43. APAC Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
Table 44. APAC Injectable Drug Delivery Formulation Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Injectable Drug Delivery Formulation Revenue Market Share by Region (2017-2022)
Table 46. APAC Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 47. APAC Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 48. APAC Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 49. APAC Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 50. Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 51. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 52. Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 54. Europe Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 55. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 56. Europe Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 57. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
Table 59. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Injectable Drug Delivery Formulation
Table 67. Key Market Challenges & Risks of Injectable Drug Delivery Formulation
Table 68. Key Industry Trends of Injectable Drug Delivery Formulation
Table 69. Injectable Drug Delivery Formulation Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Injectable Drug Delivery Formulation Distributors List
Table 72. Injectable Drug Delivery Formulation Customer List
Table 73. Global Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)
Table 74. Global Injectable Drug Delivery Formulation Sales Market Forecast by Region
Table 75. Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 78. Americas Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Injectable Drug Delivery Formulation Sales Forecast by Region (2023-2028) & (K Pcs)
Table 80. APAC Injectable Drug Delivery Formulation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Europe Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Injectable Drug Delivery Formulation Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Injectable Drug Delivery Formulation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Injectable Drug Delivery Formulation Sales Forecast by Type (2023-2028) & (K Pcs)
Table 86. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Injectable Drug Delivery Formulation Sales Forecast by Application (2023-2028) & (K Pcs)
Table 90. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Application (2023-2028)
Table 93. Becton, Dickinson and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 94. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Offered
Table 95. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 96. Becton, Dickinson and Company (US) Main Business
Table 97. Becton, Dickinson and Company (US) Latest Developments
Table 98. Baxter International Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Offered
Table 100. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Baxter International Inc. (US) Main Business
Table 102. Baxter International Inc. (US) Latest Developments
Table 103. Gerresheimer AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 104. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Offered
Table 105. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Gerresheimer AG (Germany) Main Business
Table 107. Gerresheimer AG (Germany) Latest Developments
Table 108. Pfizer, Inc. (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Offered
Table 110. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Pfizer, Inc. (US) Main Business
Table 112. Pfizer, Inc. (US) Latest Developments
Table 113. Schott AG (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 114. Schott AG (Germany) Injectable Drug Delivery Formulation Product Offered
Table 115. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. Schott AG (Germany) Main Business
Table 117. Schott AG (Germany) Latest Developments
Table 118. Sandoz (Germany) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz (Germany) Injectable Drug Delivery Formulation Product Offered
Table 120. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Sandoz (Germany) Main Business
Table 122. Sandoz (Germany) Latest Developments
Table 123. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Offered
Table 125. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. Teva Pharmaceutical Industries Ltd. (Israel) Main Business
Table 127. Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments
Table 128. Eli Lilly and Company (US) Basic Information, Injectable Drug Delivery Formulation Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Offered
Table 130. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. Eli Lilly and Company (US) Main Business
Table 132. Eli Lilly and Company (US) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Injectable Drug Delivery Formulation
Figure 2. Injectable Drug Delivery Formulation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Drug Delivery Formulation Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Injectable Drug Delivery Formulation Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Injectable Drug Delivery Formulation Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Conventional Drug Delivery Formulations
Figure 10. Product Picture of Novel Drug Delivery Formulations
Figure 11. Product Picture of Long-acting Formulations
Figure 12. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2021
Figure 13. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)
Figure 14. Injectable Drug Delivery Formulation Consumed in Autoimmune Diseases
Figure 15. Global Injectable Drug Delivery Formulation Market: Autoimmune Diseases (2017-2022) & (K Pcs)
Figure 16. Injectable Drug Delivery Formulation Consumed in Hormonal Disorders
Figure 17. Global Injectable Drug Delivery Formulation Market: Hormonal Disorders (2017-2022) & (K Pcs)
Figure 18. Injectable Drug Delivery Formulation Consumed in Oncology
Figure 19. Global Injectable Drug Delivery Formulation Market: Oncology (2017-2022) & (K Pcs)
Figure 20. Injectable Drug Delivery Formulation Consumed in Orphan Diseases
Figure 21. Global Injectable Drug Delivery Formulation Market: Orphan Diseases (2017-2022) & (K Pcs)
Figure 22. Injectable Drug Delivery Formulation Consumed in Others
Figure 23. Global Injectable Drug Delivery Formulation Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Figure 25. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2021
Figure 26. Injectable Drug Delivery Formulation Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Company in 2021
Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region in 2021
Figure 30. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region in 2021
Figure 32. Americas Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 33. Americas Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 34. APAC Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 35. APAC Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 36. Europe Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 37. Europe Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 40. Americas Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 41. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 42. United States Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Injectable Drug Delivery Formulation Sales Market Share by Region in 2021
Figure 47. APAC Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2021
Figure 48. China Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 55. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 56. Germany Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 63. Egypt Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation in 2021
Figure 69. Manufacturing Process Analysis of Injectable Drug Delivery Formulation
Figure 70. Industry Chain Structure of Injectable Drug Delivery Formulation
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Injectable Drug Delivery Formulation
Figure 2. Injectable Drug Delivery Formulation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Drug Delivery Formulation Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Injectable Drug Delivery Formulation Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Injectable Drug Delivery Formulation Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Conventional Drug Delivery Formulations
Figure 10. Product Picture of Novel Drug Delivery Formulations
Figure 11. Product Picture of Long-acting Formulations
Figure 12. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2021
Figure 13. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2022)
Figure 14. Injectable Drug Delivery Formulation Consumed in Autoimmune Diseases
Figure 15. Global Injectable Drug Delivery Formulation Market: Autoimmune Diseases (2017-2022) & (K Pcs)
Figure 16. Injectable Drug Delivery Formulation Consumed in Hormonal Disorders
Figure 17. Global Injectable Drug Delivery Formulation Market: Hormonal Disorders (2017-2022) & (K Pcs)
Figure 18. Injectable Drug Delivery Formulation Consumed in Oncology
Figure 19. Global Injectable Drug Delivery Formulation Market: Oncology (2017-2022) & (K Pcs)
Figure 20. Injectable Drug Delivery Formulation Consumed in Orphan Diseases
Figure 21. Global Injectable Drug Delivery Formulation Market: Orphan Diseases (2017-2022) & (K Pcs)
Figure 22. Injectable Drug Delivery Formulation Consumed in Others
Figure 23. Global Injectable Drug Delivery Formulation Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2022)
Figure 25. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2021
Figure 26. Injectable Drug Delivery Formulation Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Injectable Drug Delivery Formulation Revenue Market Share by Company in 2021
Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Injectable Drug Delivery Formulation Revenue Market Share by Geographic Region in 2021
Figure 30. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Country/Region in 2021
Figure 32. Americas Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 33. Americas Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 34. APAC Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 35. APAC Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 36. Europe Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 37. Europe Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Injectable Drug Delivery Formulation Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Injectable Drug Delivery Formulation Revenue 2017-2022 ($ Millions)
Figure 40. Americas Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 41. Americas Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 42. United States Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Injectable Drug Delivery Formulation Sales Market Share by Region in 2021
Figure 47. APAC Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2021
Figure 48. China Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 55. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 56. Germany Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Country in 2021
Figure 63. Egypt Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Injectable Drug Delivery Formulation Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation in 2021
Figure 69. Manufacturing Process Analysis of Injectable Drug Delivery Formulation
Figure 70. Industry Chain Structure of Injectable Drug Delivery Formulation
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
